carbamylhydrazine has been researched along with Leishmaniasis in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, AT | 1 |
| Croft, SL | 1 |
| Peters, W | 1 |
| Neal, RA | 1 |
1 other study available for carbamylhydrazine and Leishmaniasis
| Article | Year |
|---|---|
Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.
Topics: Animals; Carbidopa; Drug Evaluation, Preclinical; Drug Interactions; Leishmania donovani; Leishmania | 1989 |